Other languages Evofem Biosciences, Inc.

Equities

EVFM

US30048L3024

Market Closed - OTC Markets Other stock markets 03:58:07 2024-04-24 pm EDT			5-day change	1st Jan Change
0.0149 ^USD	+16.04%		+9.56%	-76.72%

Mar. 27	Evofem Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 27	Evofem Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Evofem Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27
Evofem Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 27
Evofem Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14
Evofem Biosciences, Inc. Provides Sales Guidance for the Third Quarter of 2023	23-10-24
Evofem Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
Evofem Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-06-16
MEI Pharma's Finance Chief Brian Drazba to Step Down; Company Names Justin File as Successor	23-06-13
MEI Pharma Names Justin File as Chief Financial Officer	23-06-13
Evofem Biosciences, Inc. Receives Paragraph IV Certification Notice Letter from Padagis Israel Pharmaceuticals Ltd	23-05-05
Evofem Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-27
Evofem Biosciences, Inc. Auditor Raises 'Going Concern' Doubt	23-04-26
Evofem Biosciences, Inc. Appoints Ivy Zhang as Secretary	23-04-14
Evofem Biosciences, Inc. Terminates Katherine Atkinson as Chief Commercial Officer	23-03-21
Evofem Biosciences, Inc. Approves a Reduction in Force	23-03-21
Evofem Biosciences, Inc.'s Phexxi Contraceptive Gel Added to SimpleHealth Product Offering	23-02-28
Evofem Biosciences to Explore and Evaluate Strategic Alternatives	23-02-23
Evofem Biosciences, Inc. Announces Resignation of Jenny Yip as Member of Board of Director	23-02-16
Evofem Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	23-01-06
Evofem Biosciences, Inc. Appoints Justin J. File as Secretary	22-12-21
Evofem Biosciences, Inc. Announces Resignation of Alexander A. Fitzpatrick as the General Counsel and Secretary	22-10-14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Evofem Biosciences, Inc.

Equities

EVFM

US30048L3024

Other languages

Filters